General physicians' perspectives on SGLT2 inhibitors for heart failure.

Lung En TengNoor LammozaAr Kar AungArchana ThayaparanSwetha VasudevanGail EdwardsMaria HormizHarry GibbsIngrid Hopper

Published in: Internal medicine journal (2024)

General physicians in Australia and Aotearoa New Zealand are familiar with the therapeutic knowledge and side effects of SGLT2is. Patient complexity, medication cost and discontinuity of care were significant barriers to the use of SGLT2is for HF among general physicians.

Keyphrases

primary care
healthcare
heart failure
palliative care
acute heart failure
case report
quality improvement
pain management
emergency department
atrial fibrillation
adverse drug
chronic pain
cardiac resynchronization therapy